» Articles » PMID: 2823697

Polysaccharides As Antiviral Agents: Antiviral Activity of Carrageenan

Overview
Specialty Pharmacology
Date 1987 Sep 1
PMID 2823697
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

A number of polysaccharides showed good antiviral activity against several animal viruses. At 5 micrograms/ml, carrageenan prevented the cell monolayer from destruction by herpes simplex virus type 1 (HSV-1) growth. At 10 micrograms/ml, carrageenan reduced the formation of new infectious HSV-1 by almost five logs. No cytotoxic effects were detected with concentrations of carrageenan up to 200 micrograms/ml. When 10 micrograms of carrageenan per ml was added at the beginning of HSV-1 infection of HeLa cells, there was potent inhibition of viral protein synthesis, and the cells continued synthesizing cellular proteins. This did not occur if carrageenan was added 1 h after HSV-1 infection. The use of [35S]methionine-labeled virions to analyze the entry of HSV-1 or Semliki Forest virions into cells indicated that carrageenan had no effect on virus attachment or virus entry. Moreover, carrageenan did not block the early permeabilization of cells to the toxic protein alpha-sarcin. These results suggest that this sulfated polysaccharide inhibits a step in virus replication subsequent to viral internalization but prior to the onset of late viral protein synthesis.

Citing Articles

Progress on the Anti-Inflammatory Activity and Structure-Efficacy Relationship of Polysaccharides from Medical and Edible Homologous Traditional Chinese Medicines.

Zhang Y, Lin X, Xia L, Xiong S, Xia B, Xie J Molecules. 2024; 29(16).

PMID: 39202931 PMC: 11356930. DOI: 10.3390/molecules29163852.


Anti-herpes simplex virus activities and mechanisms of marine derived compounds.

Hao C, Xu Z, Xu C, Yao R Front Cell Infect Microbiol. 2024; 13:1302096.

PMID: 38259968 PMC: 10800978. DOI: 10.3389/fcimb.2023.1302096.


Prospective Antiviral Effect of Aqueous Extract against COVID-19 Infection.

Binsuwaidan R, El-Masry T, El-Sheekh M, Seadawy M, Makhlof M, Aboukhatwa S Mar Drugs. 2024; 22(1).

PMID: 38248655 PMC: 10817659. DOI: 10.3390/md22010030.


Nanotechnology-driven improvisation of red algae-derived carrageenan for industrial and bio-medical applications.

James J, Verma M, Sharma N World J Microbiol Biotechnol. 2023; 40(1):4.

PMID: 37923917 DOI: 10.1007/s11274-023-03787-x.


Sulfated Polysaccharides from Seaweeds: A Promising Strategy for Combatting Viral Diseases-A Review.

Liyanage N, Nagahawatta D, Jayawardena T, Sanjeewa K, Jayawrdhana H, Kim J Mar Drugs. 2023; 21(9).

PMID: 37755074 PMC: 10532895. DOI: 10.3390/md21090461.


References
1.
Fitzgerald D, Padmanabhan R, Pastan I, Willingham M . Adenovirus-induced release of epidermal growth factor and pseudomonas toxin into the cytosol of KB cells during receptor-mediated endocytosis. Cell. 1983; 32(2):607-17. DOI: 10.1016/0092-8674(83)90480-4. View

2.
Carrasco L . Viral infection permeabilizes mammalian cells to protein toxins. Cell. 1980; 20(3):769-75. DOI: 10.1016/0092-8674(80)90323-2. View

3.
Alarcon B, Lacal J, Fernandez-Sousa J, Carrasco L . Screening for new compounds with antiherpes activity. Antiviral Res. 1984; 4(5):231-44. DOI: 10.1016/0166-3542(84)90029-9. View

4.
Munoz A, Castrillo J, Carrasco L . Modification of membrane permeability during Semliki Forest virus infection. Virology. 1985; 146(2):203-12. DOI: 10.1016/0042-6822(85)90004-2. View

5.
Farquhar C, Dickinson A . Prolongation of scrapie incubation period by an injection of dextran sulphate 500 within the month before or after infection. J Gen Virol. 1986; 67 ( Pt 3):463-73. DOI: 10.1099/0022-1317-67-3-463. View